{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:16:32Z","timestamp":1768011392337,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.ijcard.2013.08.089","type":"journal-article","created":{"date-parts":[[2013,9,7]],"date-time":"2013-09-07T19:33:43Z","timestamp":1378582423000},"page":"133-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: Results of the SCReening Evaluation of the Evolution of New Heart Failure Study (SCREEN-HF)"],"prefix":"10.1016","volume":"169","author":[{"given":"Michele","family":"McGrady","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher M.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Shiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rory","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Boffa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny","family":"Liew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duncan J","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Prior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Krum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2013.08.089_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1755-5922.2009.00075.x","article-title":"Screening: the new frontier in heart failure management","volume":"27","author":"McGrady","year":"2009","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0010","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0140-6736(10)62280-5","article-title":"Crunch time for heart failure care in England and Wales","volume":"376","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0015","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(97)03033-X","article-title":"Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population","volume":"350","author":"McDonagh","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0020","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0140-6736(01)05620-3","article-title":"Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study","volume":"358","author":"Davies","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0025","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","article-title":"Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic","volume":"289","author":"Redfield","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0030","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5694\/j.1326-5377.2006.tb00173.x","article-title":"Prevalence of heart failure and systolic ventricular dysfunction in older Australians: the Canberra Heart Study","volume":"184","author":"Abhayaratna","year":"2006","journal-title":"Med J Aust"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.290.2.199","article-title":"Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988\u20132000","volume":"290","author":"Hajjar","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pcad.2010.02.010","article-title":"The Framingham Study, diabetes mellitus and cardiovascular disease: turning back the clock","volume":"53","author":"Kengne","year":"2010","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0045","unstructured":"Dixon T, Waters AM. A growing problem: trends and patterns in overweight and obesity among adults in Australia, 1980 to 2001. Bulletin No. 8. AIHW. Cat. No. AUS 36. Canberra: AIHW, 2003."},{"key":"10.1016\/j.ijcard.2013.08.089_bb0050","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0b013e3182009701","article-title":"Heart disease and stroke statistics \u2014 2011 update: a report from the American Heart Association","volume":"123","author":"Roger","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0055","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"SOLVD","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0060","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions","volume":"327","author":"SOLVD","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0065","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(03)13501-5","article-title":"Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study","volume":"361","author":"Jong","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0070","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jacc.2004.09.054","article-title":"Diastolic dysfunction and left atrial volume: a population-based study","volume":"45","author":"Pritchett","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0075","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/bmj.325.7373.1156","article-title":"Prevalence of left ventricular systolic dysfunction and heart failure in high risk patients: community based epidemiological study","volume":"325","author":"Davis","year":"2002","journal-title":"Brit Med J"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0080","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/bmj.312.7025.222","article-title":"Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction","volume":"312","author":"Davie","year":"1996","journal-title":"Brit Med J"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0085","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0002-9343(02)01048-3","article-title":"Utility of history, physical examination, electrocardiogram, and chest radiograph for differentiating normal from decreased systolic function in patients with heart failure","volume":"112","author":"Thomas","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0090","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ahj.2004.03.034","article-title":"Electrocardiogram and B-type natriuretic peptide as screening tools for left ventricular systolic dysfunction in a population-based sample of 75-year-old men and women","volume":"148","author":"Hedberg","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0095","first-page":"191","article-title":"Screening for left ventricular systolic dysfunction using GP-reported ECGs","volume":"57","author":"Goudie","year":"2007","journal-title":"Brit J Gen Pract"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0100","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jacc.2003.10.043","article-title":"Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction","volume":"43","author":"Heidenreich","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0735-1097(02)02625-6","article-title":"Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population","volume":"41","author":"Nielsen","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0110","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/hrt.2003.026021","article-title":"Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population","volume":"90","author":"Groenning","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0115","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0140-6736(97)06031-5","article-title":"Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care","volume":"350","author":"Cowie","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMoa020233","article-title":"Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure","volume":"347","author":"Maisel","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0125","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/01.CIR.0000025242.79963.4C","article-title":"B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study","volume":"106","author":"McCullough","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0130","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/bmj.330.7492.625","article-title":"How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review","volume":"330","author":"Doust","year":"2005","journal-title":"Brit Med J"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0135","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMoa031994","article-title":"Plasma natriuretic peptide levels and the risk of cardiovascular events and death","volume":"350","author":"Wang","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0140","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/archinternmed.2010.35","article-title":"B-type natriuretic peptide-guided heart failure therapy: a meta-analysis","volume":"170","author":"Porapakkham","year":"2010","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.ijcard.2013.08.089_bb0145","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.jacc.2004.06.015","article-title":"Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT): a multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath","volume":"44","author":"Maisel","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0150","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ejheart.2006.04.004","article-title":"NTproBNP-guided drug treatment for chronic heart failure: design and methods in the BATTLESCARRED trial","volume":"8","author":"Lainchbury","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0155","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ejheart.2005.10.004","article-title":"Accuracy of B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction and heart failure: a systematic review","volume":"8","author":"Latour-Perez","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0160","series-title":"Cardiovascular survey methods","author":"Leupker","year":"2004"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0165","first-page":"1086","article-title":"American Society of Echocardiography recommendations for use of echocardiography in clinical trials","volume":"17","author":"Gottdiener","year":"2004","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0170","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/01.CIR.102.15.1788","article-title":"Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study","volume":"102","author":"Ommen","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2008.11.029","article-title":"Echocardiographic assessment of valve stenosis: EAE\/ASE recommendations for clinical practice","volume":"22","author":"Baumgartner","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0180","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0894-7317(03)00335-3","article-title":"Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography","volume":"16","author":"Zoghbi","year":"2003","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0185","series-title":"Diagnosis and management of acute rheumatic fever and rheumatic heart disease in Australia \u2014 an evidence based review","author":"National Heart Foundation of Australia (RF\/RHD guideline development working group)","year":"2006"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0190","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2307\/2532051","article-title":"A concordance correlation coefficient to evaluate reproducibility","volume":"45","author":"Lin","year":"1989","journal-title":"Biometrics"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0195","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cardfail.2008.12.002","article-title":"The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF Study","volume":"15","author":"Betti","year":"2009","journal-title":"J Card Fail"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0200","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ahj.2004.03.014","article-title":"A prospective study in search of an optimal B-natriuretic peptide level to screen patients for cardiac dysfunction","volume":"148","author":"Atisha","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0205","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJMoa031681","article-title":"Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea","volume":"350","author":"Mueller","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0210","doi-asserted-by":"crossref","first-page":"405","DOI":"10.5694\/j.1326-5377.2011.tb03031.x","article-title":"2011 Update to NHF of Australia and CSANZ Guidelines for the prevention, detection and management of chronic heart failure in Australia, 2006","volume":"194","author":"Krum","year":"2011","journal-title":"Med J Aust"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0215","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/S0735-1097(01)01672-2","article-title":"Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure","volume":"38","author":"Koglin","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0265","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S0195-668X(03)00476-7","article-title":"Clinical applications of B-type natriuretic peptide testing","volume":"24","author":"Cowie","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0230","doi-asserted-by":"crossref","first-page":"728","DOI":"10.7326\/0003-4819-153-11-201012070-00006","article-title":"Meta-analysis: effect of B-type natriuretic peptide testing on clinical outcomes in patients with acute dyspnea in the emergency setting","volume":"153","author":"Lam","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0235","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/heart.86.1.21","article-title":"Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population","volume":"86","author":"McDonagh","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0240","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/ncpcardio0156","article-title":"The prognostic value of N-terminal proB-type natriuretic peptide","volume":"2","author":"Costello-Boerrigter","year":"2005","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0245","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.cardfail.2005.06.436","article-title":"B-type natriuretic peptide testing for structural heart disease screening: a general population-based study","volume":"11","author":"Nakamura","year":"2005","journal-title":"J Card Fail"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0250","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1023\/A:1026143231117","article-title":"The role of brain natriuretic peptide in population screening","volume":"8","author":"Dyrbye","year":"2003","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0255","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1388-9842(03)00154-5","article-title":"Identification of previously undiagnosed left ventricular systolic dysfunction: community screening using natriuretic peptides and electrocardiography","volume":"5","author":"Ng","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ijcard.2013.08.089_bb0260","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/eurjhf\/hfs030","article-title":"Screening to prevent heart failure (STOP-HF): expanding the focus beyond asymptomatic left ventricular systolic dysfunction","volume":"14","author":"Murtagh","year":"2012","journal-title":"Eur J Heart Fail"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527313016720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527313016720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T11:53:51Z","timestamp":1596455631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527313016720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0167527313016720"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2013.08.089","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: Results of the SCReening Evaluation of the Evolution of New Heart Failure Study (SCREEN-HF)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2013.08.089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}